Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Incentive Equity Awards Granted By The Company) (Details)

v3.22.4
Stock-Based Compensation (Incentive Equity Awards Granted By The Company) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense $ 50    
Incentive equity awards vesting ratably over a period, in years 2 years 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted Average Grant Price, Beginning Balance (in dollars per share) $ 47.83    
Weighted Average Grant Price, Granted (in dollars per share) 51.37    
Weighted Average Grant Price, Vested (in dollars per share) [1] 47.63    
Weighted Average Grant Price, Cancelled (in dollars per share) [2] 47.97    
Weighted Average Grant Price, Ending Balance (in dollars per share) $ 48.79 $ 47.83  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]      
Number of Units, Beginning Balance (shares) 1.8    
Number of Units, Granted (shares) 0.7    
Number of Units, Vested (shares) [1] (0.5)    
Number of Units, Cancelled (shares) [2] (0.2)    
Number of Units, Ending Balance (shares) 1.8 [3] 1.8  
Performance-vested restricted Stock Units (PSUs)      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted Average Grant Price, Beginning Balance (in dollars per share) $ 48.18    
Weighted Average Grant Price, Granted (in dollars per share) 52.87    
Weighted Average Grant Price, Vested (in dollars per share) [1] 0    
Weighted Average Grant Price, Cancelled (in dollars per share) [2] 45.11    
Weighted Average Grant Price, Ending Balance (in dollars per share) $ 51.26 $ 48.18  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]      
Number of Units, Beginning Balance (shares) 0.4    
Number of Units, Granted (shares) 0.3    
Number of Units, Vested (shares) [1] 0.0    
Number of Units, Cancelled (shares) [2] (0.2)    
Number of Units, Ending Balance (shares) 0.5 [4] 0.4  
Performance-vested restricted Stock Units (PSUs) | Probable      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense $ 14    
Incentive equity awards vesting ratably over a period, in years 2 years    
Performance-vested restricted Stock Units (PSUs) | Maximum | Not probable      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense $ 20    
Incentive equity awards vesting ratably over a period, in years 1 year 3 months 18 days    
Employee Stock Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation expense $ 4    
Incentive equity awards vesting ratably over a period, in years 1 year 8 months 12 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance 2.3    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0.0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised, Number of Shares [1] 0.0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period [2] 0.0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance 2.3 [5] 2.3  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance $ 45.32    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised, Weighted Average Grant Date Fair Value [1] 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value [2] 0    
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance $ 45.36 $ 45.32  
Employee Stock Option | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period   10 years 10 years
Employee Stock Option | Exercisable options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercisable Stock Options 1.4    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 6 years 1 month 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised, Weighted Average Grant Date Fair Value $ 8.52    
[1] Upon exercise of NQs and vesting of RSUs and PSUs, the Company issues new shares to participants.
[2] The Company recognizes cancellations and forfeitures as they occur.
[3] Aggregate unrecognized compensation expense related to RSUs was $50 million as of December 31, 2022, which is expected to be recognized over a weighted average period of 2.5 years.
[4] Aggregate unrecognized compensation expense related to PSUs that are probable of vesting was $14 million as of December 31, 2022, which is expected to be recognized over a weighted average period of 2.0 years. The maximum amount of compensation expense associated with PSUs that are not probable of vesting could range up to $20 million which would be recognized over a weighted average period of 1.3 years.
[5] were 1.4 million NQs which were exercisable as of December 31, 2022. These NQs will expire over a weighted average period of 6.1 years and carry a weighted average grant date fair value of $8.52. Unrecognized compensation expense for the NQs was $4 million as of December 31, 2022, which is expected to be recognized over a weighted average period of 1.7 years.